Skip to main content

Cardiovascular Outcomes of Treatments available for Patients with Type 1 and 2 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America

  • 1st Edition, Volume 47-1 - February 9, 2018
  • Latest edition
  • Author: Guillermo E. Umpierrez
  • Language: English

This issue of Endocrinology and Metabolism Clinics, edited by Dr. Guillermo E. Umpierrez, will focus on Cardiovascular Outcomes of Treatments available for Patients with Type 1 and… Read more

Purchase options

Description

This issue of Endocrinology and Metabolism Clinics, edited by Dr. Guillermo E. Umpierrez, will focus on Cardiovascular Outcomes of Treatments available for Patients with Type 1 and 2 Diabetes. Topics include--but are not limited to--Diabetes and CAD and PVD; Prediabetes and CVD- DM prevention; Pathogenesis of atherosclerosis/CVD in diabetes Intensive Diabetes Treatment and CV Outcomes in T1D; Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, Diabetes and Stroke; Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes; Heart Failure in Diabetes Mellitus; Individualizing Glucose Lowering Therapy in the Patient with Diabetes and Heart Disease; Managing Dyslipidemia in Type 2 Diabetes; Blood pressure control and cardiovascular and renal outcomes; Hyperglycemia in acute coronary syndromes; Hospital Glucose Control; Managing Diabetes and cardiovascular risk in chronic kidney disease; and more.

Table of contents

Cardiovascular Outcomes of Treatments Available for Patients with Type 1 and 2 Diabetes – Table of Contents

Foreword: Diabetes and Atherosclerotic Cardiovascular Disease

Preface: Diabetes and Atherosclerotic Cardiovascular Disease: Novel Insights and Therapeutic Strategies

The Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes

Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions

for Prevention and Risk Reduction

Pathogenesis of Cardiovascular Disease in Diabetes

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus

Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes

Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus

Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease

Managing Dyslipidemia in Type 2 Diabetes

Blood Pressure Control and Cardiovascular/Renal Outcomes

Hyperglycemia in Acute Coronary Syndromes: From Mechanisms to Prognostic Implications

Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients

Antiplatelet Therapy in Diabetes

Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients

Product details

  • Edition: 1
  • Latest edition
  • Volume: 47-1
  • Published: February 9, 2018
  • Language: English

About the author

GU

Guillermo E. Umpierrez

Affiliations and expertise
Division of Endocrinology, Lipids, and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA